Tag
Tag: Heptares Therapeutics
British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy
Heptares and Imperial College London Will Tackle Diseases of the Gastrointestinal Tract
British Biotech Founder Receives the Nobel Prize in Chemistry 2017
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares
More News! Roche’s Stellar Hemophilia A Treatment & Two Big Rounds for Arix
A Painful Case: How Biotech is trying to Break Through in Analgesia
Heptares receives €4.5M Milestone for New Migraine Drug Candidate
Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation
Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor
